l.lokken
Submits third-party assay reports on material purchased directly. Based in Utrecht.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.19%
n=10
Suppliers covered
10
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041608 | Tirzepatide | FGP | FGP-2603-L7753 | Janoshik | 2026-Q3 | 98.87 | 2.58 | 97.5 | Buyer-sourced | 0 | PASS |
| AX-2026-043472 | CJC-1295 with DAC | BCH | BCH-2607-H5235 | PeptideMeter | 2026-Q3 | 97.58 | 5.93 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-041754 | Selank | TFS | TFS-{CAT}-1712 | PeptideMeter | 2026-Q2 | 99.93 | 7.49 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042562 | Tirzepatide | HJ | HJ-2605-D6191 | Nordanalyt | 2026-Q2 | 98.54 | 4.60 | 105.6 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-041847 | Selank | GSP | GSP-2512-H3291 | Nordanalyt | 2026-Q1 | 99.57 | 8.91 | — | Laboratory-retained | 0 | PASS |
| AX-2026-041443 | Thymosin α1 | QYB | QYB-2511-V5408 | VendorInvestigate | 2026-Q1 | 99.54 | 2.88 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042335 | Tirzepatide | TFC | TFC-2508-L2482 | Janoshik | 2026-Q1 | 98.22 | 1.30 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019813 | Semaglutide | Homopeptide | HOMO-2501-A5192 | Janoshik | 2025-Q2 | 99.52 | 6.29 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019218 | Retatrutide | SinoPep | SNP-2405-T4694 | Kestrel | 2024-Q4 | 98.86 | 4.07 | 102.8 | Supplier-supplied | 0 | PASS |
| AX-2024-004218 | Liraglutide | WWB | WWB-2406-R3462 | Medutest | 2024-Q3 | 99.67 | 2.69 | 98.6 | Buyer-sourced | 0 | PASS |